This discovery explores a possible explanation of the link between obesity and post-menopausal breast cancer, as lean women would likely have higher levels of ghrelin that would keep adipose-produced aromatase levels much lower, reducing the severity of estrogen-dependent cancers in these patients [83,86]. The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.